Improving treatment times for heart attack patients using data feedback
Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction (FITT-STEMI): A Multicenter Trial Analyzing the Effects of Systematic Data Feedback on Treatment Quality and Survival Rates.
This study is testing a new way to speed up treatment for heart attack patients to see if it helps them survive better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50000 (estimated) |
| Sex | All |
| Sponsor | St.Bernward Hospital Academic / other |
| Locations | 1 site (Hildesheim, Lower Saxony) |
| Trial ID | NCT00794001 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance treatment times for patients experiencing ST-segment elevation myocardial infarction (STEMI) through a structured approach involving data assessment and feedback. It consists of three phases: the pilot phase evaluates the reference treatment times, the implementation phase investigates the impact of systematic feedback on patient survival, and the advance phase develops an automated feedback tool for performance evaluation. The study is conducted across multiple centers, focusing on reducing the time from patient presentation to percutaneous coronary intervention (PCI). Data is collected and analyzed over five consecutive quarters to assess improvements in treatment efficiency and outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with STEMI who are transported to a primary PCI center for treatment.
Not a fit: Patients with STEMI symptoms lasting longer than 24 hours will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce treatment times and improve survival rates for patients with STEMI.
How similar studies have performed: Other studies have shown that structured feedback mechanisms can improve treatment outcomes in similar clinical scenarios, suggesting a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients who received a diagnosis of STEMI\* and were transported to the cardiac catheterization laboratory of the primary PCI center with the intention to perform primary PCI. * STEMI definition: * elevation of the ST-segments of greater than or equal to 0.1 mV in at least two contiguous limb- or precordial leads * new or presumable new left bundle branch block in the presence of typical symptoms Exclusion Criteria: * STEMI-patients with duration of infarct-related symptoms longer than 24 hours are excluded
Where this trial is running
Hildesheim, Lower Saxony
- St.Bernward Hospital — Hildesheim, Lower Saxony, Germany (Recruiting)
Study contacts
- Study coordinator: Karl H. Scholz, MD.
- Email: k.scholz@fitt-stemi.de
- Phone: +49-5121-90-1036
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.